
Galenica AG (0ROG.L)
0ROG.L Stock Price Chart
Explore Galenica AG interactive price chart. Choose custom timeframes to analyze 0ROG.L price movements and trends.
0ROG.L Company Profile
Discover essential business fundamentals and corporate details for Galenica AG (0ROG.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
7 Apr 2017
Employees
4.51K
Website
https://www.galenica.comCEO
Marc Werner
Description
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
0ROG.L Financial Timeline
Browse a chronological timeline of Galenica AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 9 Mar 2026
Upcoming earnings on 7 Aug 2025
Dividend declared on 14 Apr 2025
A dividend of CHF 2.30 per share was announced, adjusted to CHF 2.30. The dividend was paid on 16 Apr 2025.
Earnings released on 11 Mar 2025
EPS came in at CHF 2.09 surpassing the estimated CHF 1.83 by +14.21%, while revenue for the quarter reached CHF 2.02B, beating expectations by +1.71%.
Earnings released on 6 Aug 2024
EPS came in at CHF 1.58 falling short of the estimated CHF 1.69 by -6.51%, while revenue for the quarter reached CHF 1.91B, missing expectations by -1.65%.
Dividend declared on 12 Apr 2024
A dividend of CHF 2.20 per share was announced, adjusted to CHF 2.20. The dividend was paid on 16 Apr 2024.
Earnings released on 12 Mar 2024
EPS came in at CHF 1.97 surpassing the estimated CHF 1.66 by +18.67%, while revenue for the quarter reached CHF 1.89B, missing expectations by -0.01%.
Earnings released on 30 Jun 2023
EPS came in at CHF 3.75 surpassing the estimated CHF 1.56 by +140.38%, while revenue for the quarter reached CHF 1.85B, beating expectations by +0.99%.
Dividend declared on 5 May 2023
A dividend of CHF 2.20 per share was announced, adjusted to CHF 2.20. The dividend was paid on 9 May 2023.
Earnings released on 31 Dec 2022
EPS came in at CHF 1.65 surpassing the estimated CHF 1.62 by +1.85%, while revenue for the quarter reached CHF 2.05B, beating expectations by +2.01%.
Earnings released on 30 Jun 2022
EPS came in at CHF 1.67 surpassing the estimated CHF 1.61 by +3.73%, while revenue for the quarter reached CHF 1.96B, beating expectations by +4.80%.
Dividend declared on 13 May 2022
A dividend of CHF 2.10 per share was announced, adjusted to CHF 2.10. The dividend was paid on 17 May 2022.
Earnings released on 31 Dec 2021
EPS came in at CHF 1.78 surpassing the estimated CHF 1.69 by +5.33%, while revenue for the quarter reached CHF 1.98B, missing expectations by -0.02%.
Earnings released on 30 Jun 2021
EPS came in at CHF 1.60 surpassing the estimated CHF 1.50 by +6.67%, while revenue for the quarter reached CHF 1.86B, beating expectations by +3.78%.
Dividend declared on 17 May 2021
A dividend of CHF 1.80 per share was announced, adjusted to CHF 1.80. The dividend was paid on 19 May 2021.
Earnings released on 31 Dec 2020
EPS came in at CHF 2.14 surpassing the estimated CHF 1.39 by +53.96%, while revenue for the quarter reached CHF 1.79B, beating expectations by +0.02%.
0ROG.L Stock Performance
Access detailed 0ROG.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.